| scholarly article | Q13442814 |
| P2093 | author name string | Wen-Chi Chen | |
| Wei-Lun Tsai | |||
| Ping-I Hsu | |||
| Hsien-Chung Yu | |||
| Jin-Shiung Cheng | |||
| Kwok-Hung Lai | |||
| Hoi-Hung Chan | |||
| Chiun-Ku Lin | |||
| Ching-Chu Lo | |||
| Gin-Ho Lo | |||
| Chi-Pin Lin | |||
| P2860 | cites work | Epidemiology of primary liver cancer | Q33750533 |
| Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma | Q33957865 | ||
| Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection | Q34503100 | ||
| Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection | Q34533894 | ||
| Hepatocellular carcinoma: diagnosis and treatment | Q34642891 | ||
| Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies | Q35123029 | ||
| Hepatitis B virus. The major etiology of hepatocellular carcinoma | Q39199064 | ||
| Radiofrequency ablation of liver tumors: influence of technique and tumor size | Q40624405 | ||
| Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution | Q42622375 | ||
| Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis | Q42633082 | ||
| Percutaneous US-guided radiofrequency ablation of hepatocellular carcinomas: results in 15 patients. | Q43573156 | ||
| Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. | Q43601180 | ||
| Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience | Q44654109 | ||
| Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study | Q44788188 | ||
| Adverse events during radiofrequency treatment of 582 hepatic tumors. | Q45078722 | ||
| Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. | Q45846130 | ||
| Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma | Q47415758 | ||
| Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process | Q49168201 | ||
| Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer | Q71380388 | ||
| Hepatic resection for hepatocellular carcinoma. An audit of 343 patients | Q72158030 | ||
| Primary liver cancers in Japan | Q72609289 | ||
| Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation | Q73031845 | ||
| Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies | Q73490475 | ||
| Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal | Q73630413 | ||
| Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results | Q74067155 | ||
| Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years | Q74072065 | ||
| CT versus sonography for monitoring radiofrequency ablation in a porcine liver | Q74212234 | ||
| Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode | Q74408246 | ||
| Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients | Q74543135 | ||
| Local, intrahepatic, and systemic recurrence patterns after radiofrequency ablation of hepatic malignancies | Q78052598 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 1439-1444 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy | |
| P478 | volume | 11 |
| Q37174811 | Analysis of morphological vascular changes of hepatocellular carcinoma by microflow imaging using contrast-enhanced sonography |
| Q30364978 | Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma. |
| Q44379007 | Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery |
| Q53356536 | Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. |
| Q41434771 | Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas |
| Q37318880 | Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy |
| Q34003699 | Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies |
| Q33788290 | Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm |
| Q40075182 | Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors |
| Q51097786 | Potential of a no-touch pincer ablation procedure that uses a multipolar radiofrequency ablation system to prevent intrasubsegmental recurrence of small and single hepatocellular carcinomas. |
| Q40611976 | Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma |
| Q46790350 | Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization |
| Q41613592 | Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization |
| Q82258567 | Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients |
| Q84567554 | Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression |
| Q39263681 | Risk factors for early intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma in Egyptian patients |
| Q36649780 | Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors |
| Q43288271 | Sequential multidisciplinary treatment of hepatocellular carcinoma: the role of surgery as rescue therapy for failure of percutaneous ablation therapies. |
| Q51752811 | Signal intensity of small hepatocellular carcinoma on apparent diffusion coefficient mapping and outcome after radiofrequency ablation. |
| Q64097847 | Single-centre retrospective review of risk factors for local tumour progression and complications in radiofrequency ablation of 555 hepatic lesions |
| Q36734454 | Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future |
| Q91788808 | Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study |
| Q39403724 | The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma |
| Q26830236 | The Role of PET Imaging Before, During, and After Percutaneous Hepatic and Pulmonary Tumor Ablation |
| Q27016138 | Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. |
| Q36561581 | Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation |
Search more.